Bluebird's $2.8 mln gene therapy for rare blood disorder gets FDA approval
Reuters· 36 分鐘前Bluebird bio (BLUE.O) on Wednesday won U.S. approval for its gene therapy to treat a rare blood ...
Student loan repayment is set to resume in two weeks — expert believes freeze will remain
CNBC· 56 分鐘前Two weeks from today, the federal student loan repayment moratorium is scheduled to expire. The ...
'Rate hikes will have to slow at some point': Fed - RTHK
RTHK· 20 分鐘前US central bankers remain committed to raising interest rates further to quell rising prices, ...
China experiencing record temperature intensity
China Daily· 51 分鐘前The National Climate Center said on Wednesday that the intensity of China's regional high ...
Hottest Chip Maker Sees Cooling Ahead
The Wall Street Journal· 55 分鐘前Analog Devices’ unique business model has spared it from the chip slowdown so far, but its ...